Product
Glucagon-like peptide-1 receptor agonists
1 clinical trial
2 indications
Indication
chronic kidney diseaseIndication
Type 2 Diabetes MellitusClinical trial
FINErenone druG Utilization Study and Assessment of Temporal Changes Following Availability of Different Treatment Options in Patients With Chronic Kidney Disease and Type 2 DiabetesStatus: Active (not recruiting), Estimated PCD: 2025-06-30